参考文献/References:
[1] 张 婕,李建伟,张 清,等.左束支起搏对缓慢性心律失常短期疗效及安全性评估[J].陕西医学杂志,2020,49(7):844-847.
[2] 孙 贇,王曹锋,蔡文玮,等.比索洛尔对老年心律失常患者的疗效观察[J].中国急救复苏与灾害医学杂志,2020,15(z1):24-26.
[3] Zhou W,Liu H,Qiu L,et al.Cardiac efficacy and toxicity of aconitine:A new frontier for the ancient poison[J].Medicinal Research Reviews,2021,41(3):1798-1811.
[4] 胡海殷,季昭臣,于丹丹,等.中成药治疗缓慢性心律失常临床随机对照试验的网状Meta分析[J].中国中药杂志,2020,45(5):1149-1158.
[5] Ceddia R,Collins S.A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure[J].Clinical Science,2020,134(5):473-512.
[6] 杨 敏,雷瑗琳.炙甘草汤治疗心律失常随机对照试验的Meta分析[J].陕西中医,2019,40(7):968-971.
[7] 徐煜凌,周凤华,刘晓瑜,等.宁心方2号治疗缓慢性心律失常的临床研究[J].中药新药与临床药理,2019,30(2):239-244.
[8] 吴以岭.基于络病理论的中药新药研发[J].中国药理学与毒理学杂志,2019,33(9):12.
[9] 郑博鸿,詹淑玉,周鸿宇,等.生脉注射液物质组成临床前药动学和药效学的研究进展[J].中草药,2020,51(20):5360-5371.
[10] 杨昊昕,戴雁彦,宫僖浩,等.参松养心胶囊治疗缓慢性心律失常合并早搏的疗效和安全性系统评价及Meta分析[J].中国中药杂志,2020,45(2):222-229.
[11] 刘功来,杨 威,王云霞,等.葛根素对大鼠心肌缺血再灌注诱导心律失常的影响及作用机制[J].基因组学与应用生物学,2020,39(7):3350-3354.
[12] Yan D,Xu XR,Qian YL,et al.Chinese patent medicine to treat a 32-year-old man with sinus bradycardia and cardiac sinus arrests:A case report[J].Medicine,2019,98(19):155-156.
[13] Herrmann F,Graf H,Wellmann P,et al.Etiology of tricuspid valve disease is a predictor of bradyarrhythmia after tricuspid valve surgery[J].Journal of Cardiovascular Electrophysiology,2019,30(7):1108-1116.
[14] Lee C,Davidsen JM,Skals R,et al.Recurrent syncope in patients with a pacemaker and bradyarrhythmia[J].European Heart Journal,2020,41(2):715.
[15] Chen S,Zhang Y,Lighthouse JK,et al.A novel role of cyclic nucleotide phosphodiesterase 10A in pathological cardiac remodeling and dysfunction[J].Circulation,2019,141(3):217-233.
[16] Bork NI,Pavlidou NG,Reiter B,et al.P2863 regional specific remodeling of cGMP pathway in human atrial fibrillation[J].European Heart Journal,2019,40(1):1806-1809.
[17] Flueck C,Drought LG,Jones A,et al.Phosphodiesterase beta is the master regulator of cAMP signalling during malaria parasite invasion[J].PLoS Biology,2019,17(2):e300-e304.
[18] Dunkerly EB,Kass DA.Myocardial phosphodiesterases and their role in cGMP regulation[J].Journal of Cardiovascular Pharmacology,2020,75(6):483-493.
[19] Si LJ,Pan LQ,Zhang X,et al.Evidence that dopamine is involved in neuroendocrine regulation gill intracellular signaling pathways and ion regulation in litopenaeus vannamei[J].The Journal of Experimental Biology,2019,222(15):204-207.
[20] 张德芹,高学敏,张 聪,等.“养心理论”构建与养心氏片组方理论探析[J].中西医结合心脑血管病杂志,2017,15(2):244-247.